See also this year's filing and all EDGAR filings for this company.
PDF Report 0001236997_2019_Counterpath_CORP.pdf
Logs
warning | The stock price does not exist | industry.us_generic | {} |
warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
warning | No stock price available | subcommand.plot | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001236997')"} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001236997, Counterpath CORP
xvar | xval | |
---|---|---|
0 | LiabilitiesCurrent | 5,068,939 |
1 | LongTermDebt | 0 |
2 | remainder_Liabilities | 24,102 |
3 | IntangibleAssets | 7,064,637 |
4 | AssetsNoncurrent | 0 |
5 | AssetsCurrent | 6,049,138 |
6 | PropertyPlantAndEquipmentNet | 121,819 |
7 | remainder_Assets | 98,633 |
8 | SellingAndMarketingExpense | 4,266,716 |
9 | GeneralAndAdministrativeExpense | 3,772,094 |
10 | ResearchAndDevelopmentExpense | 5,506,887 |
11 | remainder_Expenses | 1,629,814 |
12 | remainder_Revenues | 12,381,741 |
13 | remainder_NetIncome | -426,900 |
14 | remainder_ComprehensiveNetIncome | 791,955 |
yvar | yval | |
---|---|---|
0 | Liabilities | 5,093,041 |
1 | Assets | 13,334,227 |
2 | Expenses | 15,175,511 |
3 | Revenues | 12,381,741 |
4 | StockholdersEquity | 8,241,186 |
5 | NetIncome | -3,220,670 |
6 | ComprehensiveNetIncome | -2,428,715 |
7 | BaseVar | 23,601,688 |
8 | EconomicCapitalRatiobeforeLimitedLiability | 2.69 |
9 | EconomicCapitalRatio | 4.33 |